Know Cancer

or
forgot password

The Feasibility and Acceptability of Using the Delphi Screener for Cervical Cytology Testing Among Low Income Women in New York City


Phase 2
18 Years
N/A
Not Enrolling
Female
Cervical Neoplasia

Thank you

Trial Information

The Feasibility and Acceptability of Using the Delphi Screener for Cervical Cytology Testing Among Low Income Women in New York City


Inclusion Criteria:



- Valid Pap smear in last 1-3 months obtained at participating clinic

- 18 years or older

- Self-report being able to read in English and/or Spanish

- Willing to sign informed consent

Exclusion Criteria:

- Used vaginal product (douche, spermicide, antifungal) in last 48 hours

- Last menses started ≤ 4 days prior to enrollment visit

- No uterus / history of hysterectomy

- Self-report currently pregnant

- Self-report currently breastfeeding

Type of Study:

Interventional

Study Design:

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Screening

Outcome Measure:

Outcome Measure: sensitivity, specificity, kappa compared to gold standard

Outcome Time Frame:

cross-sectional

Safety Issue:

No

Principal Investigator

Carolyn Westhoff, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Columbia University

Authority:

United States: Institutional Review Board

Study ID:

AAAD1382

NCT ID:

NCT00702208

Start Date:

September 2008

Completion Date:

January 2010

Related Keywords:

  • Cervical Neoplasia
  • cervical cytology
  • Pap smear
  • self-sampling
  • abnormal
  • normal
  • Neoplasms

Name

Location

Columbia University Presbyterian HospitalNew York, New York  10032